James B. Wetmore

6.1k total citations · 1 hit paper
137 papers, 2.9k citations indexed

About

James B. Wetmore is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, James B. Wetmore has authored 137 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Nephrology, 39 papers in Cardiology and Cardiovascular Medicine and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in James B. Wetmore's work include Dialysis and Renal Disease Management (47 papers), Parathyroid Disorders and Treatments (25 papers) and Blood Pressure and Hypertension Studies (19 papers). James B. Wetmore is often cited by papers focused on Dialysis and Renal Disease Management (47 papers), Parathyroid Disorders and Treatments (25 papers) and Blood Pressure and Hypertension Studies (19 papers). James B. Wetmore collaborates with scholars based in United States, Australia and United Kingdom. James B. Wetmore's co-authors include David T. Gilbertson, Jiannong Liu, Allan J. Collins, Theresa I. Shireman, John A. Spertus, Jonathan D. Mahnken, L. Darryl Quarles, Connie J. Wang, Brian D. Bradbury and Jason R. Stubbs and has published in prestigious journals such as PLoS ONE, Endocrine Reviews and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

James B. Wetmore

126 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden

2015 358 citations Jason R. Stubbs, James B. Wetmore et al. Journal of the American Society of Nephrology profile →

Peers

Countries citing papers authored by James B. Wetmore

Since Specialization

Citations

This map shows the geographic impact of James B. Wetmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B. Wetmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B. Wetmore more than expected).

Fields of papers citing papers by James B. Wetmore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James B. Wetmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B. Wetmore. The network helps show where James B. Wetmore may publish in the future.

Co-authorship network of co-authors of James B. Wetmore

This figure shows the co-authorship network connecting the top 25 collaborators of James B. Wetmore. A scholar is included among the top collaborators of James B. Wetmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James B. Wetmore. James B. Wetmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Peritoneal Dialysis-Associated Peritonitis Rates in the Outpatient and Hospital Setting Among Incident Dialysis Patients With Medicare, 2009–2018 2024 ·Kidney Medicine ·(unknown), Shuling Li, (unknown), James B. Wetmore, Kirsten L. Johansen	0
2	Classification of chronic kidney disease in older Australian adults by the CKD‐EPI 2009 and 2021 equations: secondary analysis of ASPREE study data 2024 ·The Medical Journal of Australia ·(unknown), Rory Wolfe, James B. Wetmore, Anne M. Murray, Robyn L. Woods, Michelle A. Fravel, Mark Nelson, Nigel Stocks, Suzanne G. Orchard, Kevan R. Polkinghorne	0
3	Effects of statins on kidney function in older adults 2024 ·Journal of the American Geriatrics Society ·Michelle A. Fravel, Michael E. Ernst, Robyn L. Woods, Suzanne G. Orchard, (unknown), Rory Wolfe, James B. Wetmore, Mark Nelson, (unknown), Anne M. Murray, Sophia Zoungas, Zhen Zhou	1
4	Association Between CKD and Major Hemorrhage in Older Persons: Data From the Aspirin in Reducing Events in the Elderly Randomized Trial 2023 ·Kidney International Reports ·Suzanne E. Mahady, Lê Thị Phương Thảo, Robyn L. Woods, Rory Wolfe, James B. Wetmore, Karen L. Margolis, Erica M. Wood, Geoffrey Cloud, Anne M. Murray, Kevan R. Polkinghorne	9
5	Symptom Trajectories in the Electronic Health Record during the Transition to Maintenance Dialysis 2023 ·Clinical Journal of the American Society of Nephrology ·James B. Wetmore, Kirsten L. Johansen, David T. Gilbertson, Nicholas S. Roetker	3
6	Increased Access, Persistent Disparities 2023 ·Clinical Journal of the American Society of Nephrology ·(unknown), Shuling Li, (unknown), David T. Gilbertson, Eric D. Weinhandl, James B. Wetmore, Allyson Hart, Kirsten L. Johansen	3
7	COVID-19 and kidney disease: insights from epidemiology to inform clinical practice 2022 ·Nature Reviews Nephrology ·Viyaasan Mahalingasivam, Guobin Su, Masao Iwagami, Mogamat Razeen Davids, James B. Wetmore, Dorothea Nitsch	48
8	Hemodialysis Vascular Access and Risk of Major Bleeding, Thrombosis, and Cardiovascular Events: A Cohort Study 2022 ·Kidney Medicine ·Nicholas S. Roetker, Haifeng Guo, Dena Rosen Ramey, Ciaran J. McMullan, G. Brandon Atkins, James B. Wetmore	4
9	CKD Biomarkers, Cognitive Impairment, and Incident Dementia in an Older Healthy Cohort 2021 ·Kidney360 ·Anne M. Murray, Lê Thị Phương Thảo, Joanne Ryan, Rory Wolfe, James B. Wetmore, Robyn L. Woods, Kevan R. Polkinghorne	11
10	Changes in Treatment of Patients with Incident ESKD during the Novel Coronavirus Disease 2019 Pandemic 2021 ·Journal of the American Society of Nephrology ·James B. Wetmore, Kirsten L. Johansen, Jiannong Liu, Yi Peng, David T. Gilbertson, Eric D. Weinhandl	11
11	Initial Effects of COVID-19 on Patients with ESKD 2021 ·Journal of the American Society of Nephrology ·Eric D. Weinhandl, James B. Wetmore, Yi Peng, Jiannong Liu, David T. Gilbertson, Kirsten L. Johansen	47
12	Geographic Variation of Home Dialysis Utilization in the United States 2020 ·Journal of the American Society of Nephrology ·Eric D. Weinhandl, David T. Gilbertson, James B. Wetmore, Kirsten L. Johansen	0
13	Myopericarditis in a patient with hepatitis C and cryoglobulinemic renal disease 2017 ·Clinical Case Reports ·(unknown), (unknown), Bradley M. Linzie, (unknown), James B. Wetmore	4
14	The rise of FGF23: should insights from population-based studies inform future clinical trials? 2016 ·Kidney International ·James B. Wetmore	1
15	Ergocalciferol versus Cholecalciferol for Nutritional Vitamin D Replacement in CKD 2015 ·The Nephron journals/Nephron journals ·Roberto Mangoo‐Karim, (unknown), George P. Yanev, (unknown), Jason R. Stubbs, James B. Wetmore	13
16	Association between higher rates of cardioprotective drug use and survival in patients on dialysis 2014 ·Research in Social and Administrative Pharmacy ·Yuexin Tang, John M. Brooks, James B. Wetmore, Theresa I. Shireman	9
17	Association of Race with Cumulative Exposure to Statins in Dialysis 2012 ·American Journal of Nephrology ·James B. Wetmore, Jonathan D. Mahnken, Sally K. Rigler, Edward F. Ellerbeck, Purna Mukhopadhyay, Qingjiang Hou, Theresa I. Shireman	6
18	Geographic Variation in HMG-CoA Reductase Inhibitor Use in Dialysis Patients 2012 ·Journal of General Internal Medicine ·James B. Wetmore, Jonathan D. Mahnken, Purna Mukhopadhyay, Qingjiang Hou, Edward F. Ellerbeck, Sally K. Rigler, John A. Spertus, Theresa I. Shireman	4
19	Considering health insurance: how do dialysis initiates with Medicaid coverage differ from persons without Medicaid coverage? 2009 ·Nephrology Dialysis Transplantation ·James B. Wetmore, Sally K. Rigler, (unknown), Purna Mukhopadhyay, Theresa I. Shireman	17
20	Interleukin-1 gene cluster polymorphisms predict risk of ESRD 2005 ·Kidney International ·James B. Wetmore, Adriana M. Hung, David H. Lovett, Śaunak Sen, (unknown), Kirsten L. Johansen	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact